शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
FORTISBSEFORTIS HEALTHCARE LTD· Healthcare ServicesHighNeutral
Announced Thu, 6 Aug, 2026 · 19:08 IST

Fortis Q1 FY27 revenue up 13% YoY at Rs 489 cr, PAT at Rs 47.8 cr

Emphasis of matterExceptional itemEBITDA margin expansionRelated-party transactionsResults View source PDFExplain this filing

FORTIS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+4.3%Reaction day
₹920.00
prior close
₹920.00
announcement price
After-mkt
timing
Nifty Midcap 150market+0.2%+4.1% vs market
Hospital peers, median of 26sector+0.2%+4.1% vs sector

On the reaction day the stock moved 4.1 pts more than Nifty Midcap 150 and 4.1 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.3
10m
+1.0
15m
+1.2
30m
+2.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+4.3+0.2+4.1+0.2+4.1
Next day
+2.7+0.7+2.0-0.1+2.9
2d
+1.4+0.6+0.8-0.4+1.9
3d
-3.7+0.9-4.6-1.9-1.8
4d
-1.8+1.0-2.7-3.0+1.2
5d
+1.0+0.5+0.5-1.7+2.7
1w
-0.4+0.2-0.6-1.6+1.2
15d
+1.2+0.8+0.4-3.1+4.3
1m
-1.1-1.1-0.0-2.5+1.5
2m
-15.2-6.3-8.9-9.3-5.9
3m
—————
UpDownMarket · Nifty Midcap 150Sector · Hospital peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Fortis Q1 FY27 standalone revenue rose 13% YoY to Rs 489 cr from Rs 433 cr. Net profit at Rs 47.8 cr versus Rs 51.9 cr, helped by Rs 13.3 cr exceptional gain (subsidiary impairment reversal). EBITDA at Rs 122.9 cr; operating margin improved to 21.24% from 20.35%. Limited review report is clean. Auditor flagged ongoing SFIO probe and Supreme Court matter on RHT Health Trust as emphasis of matter.

Likely market impact

Flat underlying earnings; exceptional gain cushioned PAT. Clean audit, but legacy legal overhangs from past promoter issues remain. Margin improved.